Akron CEO Zylberberg interviewed for the Innate Killer Summit 2018

The Innate Killer Summit is the leading, dedicated end-to-end meeting serving as the catalyst to ensure successful clinical and commercial translation of Natural Killer (NK) cell immunotherapies. Leading up to the March 2018 event in San Diego, CA, Akron Biotechnology CEO Claudia Zylberberg, Ph.D. shared some key issues and questions arising in the NK therapy

Claudia Zylberberg interviewed for ‘Marketing Matters’ on Sirius XM Business Radio

This past week, Akron Biotech’s CEO Claudia Zylberberg was interviewed for Marketing Matters, a Sirius XM Business Radio show. Dr. Zylberberg appeared on the November 1, 2017 show to discuss how Akron Biotechnology has leveraged offline opportunities together with their online presence to enhance their brand. Marketing Matters is hosted by Wharton Marketing Professor Barbara Kahn and

Akron participates in panel on human platelet lysate at AABB Annual Meeting

The 2017 Annual Meeting of the American Association of Blood Banks (AABB) took place from October 7 – 10, 2017 in San Diego, CA. Akron Biotechnology participated in a panel as part of the AABB/ISCT Joint Working Group, Pooled Human Platelet Lysate (pHPL) for Cell Therapies Manufacturing. The thrust for this meeting comes from the increasing prevalence and

From sterile filling to custom manufacturing: How Akron’s unique services and capabilities can work for you

Akron’s sterile manufacturing facility, presented here before, enables the unique preparation of products within a fully aseptic manufacturing environment, including sterile filtration and container-closure filling. And while this allows Akron to manufacture cGMP-compliant, sterile-filled cytokines and ancillary materials for cell therapy, Akron also extends these capabilities as services to serve the industry: Owing to our unique facilities, our manufacturing capabilities are among

The cytokine supplier difference: Sterile fill/finish

The supply of critical raw materials for cell therapy manufacturing must fulfill the need for cost-effective, safe and functional products that provide reliable and reproducible performance. In case of cytokines, these products are proteins that must fulfill the need for stability, functionality and be contamination-free. Within stability and functionality, considerations of three-dimensional structure and affect

Mycoplasma detection: Speed and sensitivity calls for a shift to RT-PCR-based methods

  Mycoplasma contamination of cell cultures is an alarming reality: 25% of all cultures are reported to be contaminated with Mycoplasma, and further challenges – such as the fact Mycoplasma is hard to detect with regular light microscopes – make these numbers even more urgent. Mycoplasmas are very small prokaryotes which lack a cell wall. The best option for mycoplasma-infected cell

The new akronbiotech.com ushers Akron into the future

Following an eventful week at Phacilitate’s Cell and Gene Therapy World Forum in Miami, Akron just unveiled its new website, which can be accessed at www.akronbiotech.com. The new website sports a brand new look alongside a refreshed logo, which features Akron’s recognizable image that has been updated for the new year. Since 2006, Akron gone through multiple changes, and the